Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Hepatocellular

Carcinoma, Renal Cell

Prostatic Neoplasms

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Neoplasms

Hematologic Neoplasms

Brain Neoplasms

Urinary Bladder Neoplasms

Prostatic Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Non-Small-Cell Lung

Kidney Neoplasms

Prostate Cancer Metastatic Disease

Lung Neoplasms

Pancreatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Colorectal Neoplasms

Pancreatic Neoplasms

Stomach Neoplasms

Neoplasm Metastasis, Neoplasms, Neoplasms, Second Primary

Carcinoma, Hepatocellular

Neoplasm Metastasis

Carcinoma, Pancreatic Ductal

Esophageal Neoplasms, Lung Neoplasms, Neoplasms

Breast Neoplasms

Prostatic Neoplasms

Advanced Pancreatic Cancer

Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer

Locally Advanced Pancreatic Cancer

Carcinoma, Non-Small-Cell Lung

Lung Metastases

Colorectal Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Renal Cell

Clinical Trials

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

Botensilimab, Balstilimab, and SBRT in Colorectal Cancer

Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial

Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

PROSTERA

Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases

The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating

NeoSRS

A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

ARPEGGIO

VVSHIP

SBRT Versus Surgical Resection for Small HCC

Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer

SACTION 2501

SBRTRC

HIMARS

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

RAD-NALIRIFOX

TOPPGUN-RS

MRI-guided Locoregional SBRT Prostate Program

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver Metastasis

Ivonescimab With GnP and SBRT in Patients With Metastatic Pancreatic Cancer (WGOG-PAN 004)

Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic Progression

Abscopal Effect from Low-dose Radiotherapy in Metastatic Cancer Combined with Stereotactic Body Radiotherapy

Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment

RESTO-IMMUNO

Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC

REPAIR

STAR-B

Adaptive MR-guided SBRT for Localized Prostate Cancer

Nim-PC-28

Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer

SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)

CULTRO

COPPER

SBRT Combined With Fruquintinib Plus PD-1/CTLA-4 Antibody for Third-line Treatment in mCRC

Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study

AQuOS-II